Additionally, previous studies have shown that culturing CD4+ T-cells with C1q inhibits proliferation in a dose-dependent manner, suggesting that a lack of C1q-mediated T-cell immunosuppression could contribute to SLE pathogenesis [21,22]. The gene discussed is CD4; the disease is systemic lupus erythematosus.